Heterocyclic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device
US-2024373662-A1 · Nov 7, 2024 · US
US11239434B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11239434-B2 |
| Application number | US-201916243655-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 9, 2019 |
| Priority date | Feb 9, 2018 |
| Publication date | Feb 1, 2022 |
| Grant date | Feb 1, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A compound including a first ligand L A of Formula I is disclosed.
Opening claim text (preview).
We claim: 1. A compound comprising: a first ligand L A of Formula I wherein, Ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; Z 1 , Z 2 , and Z 3 are each independently selected from the group comprising C and N; Y is selected from the group consisting of O, S, Se, NR 3 , CRR′, SiRR′, GeRR′, and a single bond; Y is not CRR′ when Z 1 , Z 2 , and Z 3 are C; if Y is a single bond, then Z 3 is C and Ring A is not pyridine or if Y is a single bond and Ring A is pyridine, then at least one of Z 1 , Z 2 , or Z 3 is N; a metal M forms a direct bond to Ring A or Ring B; M is selected from the group consisting of Os, Ir, Pd, Pt, Cu, and Au; R A and R B each independently represents mono to a maximum possible number of substitutions, or no substitution; R A , R B , R 1 , R 2 , R 3 , R, and R′ are each independently a hydrogen or a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; one of R A or R B is a 5-membered or 6-membered aromatic ring that is bonded to M; the ligand L A is optionally linked with other ligands to form a ligand having a denticity of tridentate to a maximum possible denticity to which M can coordinate; any two substituents may be joined or fused together to form a ring, provided that R 1 and R 2 are not joined to form a 6-membered aromatic ring when Y is a single bond; and M is optionally coordinated to other ligands. 2. The compound of claim 1 , wherein R A , R B , R 1 , R 2 , R 3 , R, and R′ are each independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof. 3. The compound of claim 1 , wherein M is selected from the group consisting of Ir and Pt. 4. The compound of claim 1 , wherein Y is a single bond or selected from the group consisting of O, S, and NR 3 . 5. The compound of claim 1 , wherein one of R A or R B comprises a benzene ring, that is bonded to M. 6. The compound of claim 1 , wherein one of R A or R B comprises a pyridine ring, that is bonded to M. 7. The compound of claim 1 , wherein one of Z 1 , Z 2 , or Z 3 is N and forms a dative bond to M, and the remaining two of Z 1 , Z 2 , and Z 3 are C. 8. The compound of claim 1 , wherein Ring A contains an N atom that forms a dative bond to M. 9. The compound of claim 1 , wherein Ring A is a 5-membered aromatic ring or a 6-membered aromatic ring. 10. The compound of claim 1 , wherein the first ligand L A is selected from the group consisting of: wherein, R C represents mono to a maximum possible number of substitutions, or no substitution; and R C and R 4 are each independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof. 11. The compound of claim 1 , wherein L A is selected from the group consisting of L A1 through L A294 having structures of Formula I wherein R 1 , R 2 , R 5 , R 6 , and R 7 are defined as follows: Ligand R 1 R 2 R 7 R 6 R 5 L A1 H H H H H L A2 R B1 H H H H L A3 R B1 R B1 H H H L A4 R B1 R B1 R B1 H H L A5 R B1 H R B1 H H L A6 H H R B1 H H L A7 H H H R B1 R B1 L A8 R B1 H H R B1 R B1 L A9 R B1 R B1 H R B1 R B1 L A10 R B1 R B1 R B1 R B1 R B1 L A11 R B1 H R B1 R B1 R B1 L A12 H H R B1 R B1 R B1 L A13 H H H R B44 R B44 L A14 R B1 H H R B44 R B44 L A15 R B1 R B1 H
containing organic luminescent materials · CPC title
comprising iridium · CPC title
Iridium compounds · CPC title
of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title
Electricity · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.